• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION (US) 2.75/40; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION (US) 2.75/40; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 453975
Medical Device Problem Code Inflation Problem (1310)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/21/2022
Type of Reportable Event Malfunction
Event or Problem Description
An orsiro mission drug-eluting stent system was selected for treatment.After predilatation of a calcified lesion in the rca, the device was inserted, but when inflating up to normal pressure, no expansion of the stent was visible.The device was removed and inspected and was found still crimped on the balloon.Outside patients body the stent could be expanded.
 
Additional Manufacturer Narrative
Combination product: yes.
 
Additional Manufacturer Narrative
Combination product: yes.Only the stent was returned and subjected to a technical analysis.The product release documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.In addition, photographs and videos taken from the angiogram were reviewed.The stent was returned in a plastic beaker.The stent has been dilated and is deformed (i.E.Pinched) over its entire length.Review of the photographs and videos taken from the angiogram did not provide any further relevant information with regards to the root cause of the complaint.Review of the product release documentation confirmed that the instrument was manufactured according to specifications and passed all in-process and final inspections.In addition to visual inspections each instrument is tested for air tightness by means of a helium leak test.Based on the conducted investigations of the device being subject to this complaint, no material or manufacturing related root cause was determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO MISSION (US) 2.75/40
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key15987799
Report Number1028232-2022-06475
Device Sequence Number17694448
Product Code NIQ
UDI-Device Identifier07640130456310
UDI-Public(01)07640130456310(17)2403
Combination Product (Y/N)Y
Initial Reporter CountryUS
PMA/510(K) Number
P170030
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/08/2024
Device Model Number453975
Device Catalogue NumberSEE MODEL NO.
Device Lot Number02224881
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/01/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/28/2022
Supplement Date Received by Manufacturer01/06/2023
Initial Report FDA Received Date12/15/2022
Supplement Report FDA Received Date01/09/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/09/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization;
Patient SexUnknown
-
-